AQR Capital Management’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $207K | Sell |
6,381
-191
| -3% | -$6.21K | ﹤0.01% | 3032 |
|
|
2025
Q1 | $248K | Sell |
6,572
-17,944
| -73% | -$678K | ﹤0.01% | 2775 |
|
|
2024
Q4 | $2.01M | Buy |
24,516
+13,403
| +121% | +$1.1M | ﹤0.01% | 1536 |
|
|
2024
Q3 | $1.27M | Buy |
11,113
+253
| +2% | +$28.9K | ﹤0.01% | 1737 |
|
|
2024
Q2 | $820K | Buy |
10,860
+328
| +3% | +$24.8K | ﹤0.01% | 1841 |
|
|
2024
Q1 | $719K | Sell |
10,532
-1,568
| -13% | -$107K | ﹤0.01% | 1819 |
|
|
2023
Q4 | $760K | Sell |
12,100
-400
| -3% | -$25.1K | ﹤0.01% | 1709 |
|
|
2023
Q3 | $637K | Sell |
12,500
-1,870
| -13% | -$95.3K | ﹤0.01% | 1765 |
|
|
2023
Q2 | $718K | Buy |
14,370
+1,627
| +13% | +$81.3K | ﹤0.01% | 1685 |
|
|
2023
Q1 | $478K | Buy |
12,743
+1,306
| +11% | +$48.9K | ﹤0.01% | 1796 |
|
|
2022
Q4 | $548K | Buy |
11,437
+2,111
| +23% | +$101K | ﹤0.01% | 1781 |
|
|
2022
Q3 | $224K | Buy |
+9,326
| New | +$224K | ﹤0.01% | 2020 |
|